title: Cost-effectiveness of infertility treatments: a cohort study.
abstract: OBJECTIVE
  To determine the cost-effectiveness of infertility treatments.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  Academic medical center infertility practice.
  
  
  METHODS
  All patients treated for infertility in a 1-year time span.
  
  
  METHODS
  Intrauterine inseminations, clomiphene citrate and IUI (CC-IUI), hMG and IUI (hMG-IUI), assisted reproductive techniques (ART), and neosalpingostomy by laparotomy.
  
  
  METHODS
  All medical charges and pregnancy outcomes associated with the treatments were obtained. Cost-effectiveness ratios defined as cost per delivery were determined for each procedure. The effects of a woman's age and the number of spermatozoa inseminated on cost-effectiveness of the procedures was also determined.
  
  
  RESULTS
  Intrauterine inseminations, CC-IUI, and hMG-IUI have a similar cost per delivery of between $7,800 and $10,300. All of these were more cost-effective than ART, which had a cost per delivery of $37,000. Assisted reproductive techniques in women with blocked fallopian tubes was more cost-effective than tubal surgery performed by laparotomy, which had a cost per delivery of $76,000. Increasing age in women and lower numbers of spermatozoa inseminated were factors leading to higher costs per delivery for IUI, CC-IUI, hMG-IUI, and ART. Use of donor oocytes reduced the cost per delivery of older women to the range seen in younger women with ART.
  
  
  CONCLUSIONS
  Our analysis supports, in general, the use of IUI, CC-IUI, and hMG-IUI before ART in women with open fallopian tubes. For women with blocked fallopian tubes, IVF-ET appears to be the best treatment from a cost-effectiveness standpoint.
authors.affiliation: Division of Reproductive Endocrinology, University of Iowa College of Medicine, Iowa City, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Van Voorhis
authors.forename: A E
authors.initials: AE
authors.lastname: Sparks
authors.forename: B D
authors.initials: BD
authors.lastname: Allen
authors.forename: D W
authors.initials: DW
authors.lastname: Stovall
authors.forename: C H
authors.initials: CH
authors.lastname: Syrop
authors.forename: F K
authors.initials: FK
authors.lastname: Chapler
mesh_terms: D002996:Clomiphene / Q000627:therapeutic use; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D004624:Embryo Transfer / Q000191:economics; D005184:Fallopian Tube Diseases / Q000150:complications / Q000601:surgery; D005260:Female; D005307:Fertilization in Vitro / Q000191:economics; D006801:Humans; D007246:Infertility / Q000191:economics* / Q000628:therapy*; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D007317:Insemination, Artificial, Homologous / Q000191:economics; D008297:Male; D008596:Menotropins / Q000627:therapeutic use; D010062:Ovulation Induction / Q000191:economics; D011247:Pregnancy; D012099:Reproductive Techniques / Q000191:economics*
chemical_list: D002996:Clomiphene; D008596:Menotropins